Recurrent Vulvovaginal Candidiasis Due to Irrational Drug Use in a Teenager: Debunking the Myth of “Toilet Infection”
Main Article Content
Abstract
Vulvovaginal candidiasis (VVC) is a common, discomforting, and embarrassing condition that can recur in healthy women. The irrational use of antibiotics is one of its often unexplored causes by primary care physicians. An 18-year-old university undergraduate presented with a three-day history of vulvovaginal itching and discharge, which had occurred repeatedly. She was evaluated and diagnosed with recurrent vulvovaginal candidiasis, associated with the recurrent use of doxycycline. She was successfully managed with oral fluconazole and received appropriate patient education. Primary care physicians should thoroughly explore drug use history in healthy women presenting with recurrent VVC and offer appropriate patient education.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal Candidiasis: A Current Understanding and Burning Questions. J fungi 2020;6(1):1–20.
Olowe OA, Makanjuola OB, Olowe R, Adekanle DA. Prevalence of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis among pregnant women receiving antenatal care in Southwestern Nigeria. Eur J Microbiol Immunol. 2014;4(4):193–7.
Mbakwem-Aniebo C, Osadebe AU, Athanasonny E, Okonko IO. Prevalence of Candida spp. and age-related disparities amongst women
presenting with vaginitis at the obstetrics and gynaecology (O&G) clinic in a tertiary hospital in Port Harcourt, Nigeria. Afr Health Sci. 2020;20(1):51–8.
Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent Vulvovaginal Candidiasis: An Immunological Perspective. Microorganisms 2020;8(2):1–14.
Ugwa EA. Vulvovaginal Candidiasis in Aminu Kano Teaching Hospital, North-West Nigeria: Hospital-Based Epidemiological Study. Ann Med Health Sci Res. 2015;5(4):274-8.
Ogedegbe EE, Henshaw B. Severity and impact of acne vulgaris on the quality of life of adolescents in Nigeria. Clin CosmetInvestig Dermatol. 2014;7(1):329-334.
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, et al. Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k). Mycoses. 2021;64(6):583–602.
Paladine HL, Desai UA. Vaginitis: Diagnosis and Treatment. Am Fam Physician. 2018;97(5):321–9.
Aniebue UU, Nwankwo TO, Nwafor MI. Vulvovaginal candidiasis in reproductive age women in Enugu Nigeria, clinical versus laboratory-assisted diagnosis. Niger J Clin Pract. 2018;21(8):1017–22.
Dovnik A, Golle A, Novak D, Arko D, Takač I. Treatment of vulvovaginal candidiasis: A review of the literature. Acta Dermatovenerologica Alpina, Pannonica Adriat. 2015;24(1):5–7.